(Q50106577)

25 February 2018

title

Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. (English)

1 reference

25 February 2018

author

Dominique Guyader

5

1 reference

25 February 2018

author name string

Ludivine Falize

1

1 reference

25 February 2018

Anne Guillygomarc'h

2

1 reference

25 February 2018

Michele Perrin

3

1 reference

25 February 2018

Fabrice Lainé

4

1 reference

25 February 2018

Pierre Brissot

6

1 reference

25 February 2018

Bruno Turlin

7

1 reference

25 February 2018

Yves Deugnier

8

1 reference

25 February 2018

language of work or name

English

0 references

publication date

1 August 2006

1 reference

25 February 2018

published in

Hepatology

1 reference

25 February 2018

volume

44

1 reference

25 February 2018

issue

2

1 reference

25 February 2018

page(s)

472-477

1 reference

25 February 2018

Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat

cites work

1 reference

7 January 2021

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

7 January 2021

Histological improvement after anti-viral treatment for chronic hepatitis B virus infection

1 reference

7 January 2021

Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort

1 reference

7 January 2021

Reversibility of cirrhosis in chronic hepatitis B.

1 reference

7 January 2021

Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy

1 reference

7 January 2021

Reversal of “Cirrhosis” in Idiopathic Haemochromatosis Following Long-term Intensive Venesection Therapy

1 reference

7 January 2021

Long-term survival in patients with hereditary hemochromatosis

1 reference

7 January 2021

Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment

1 reference

7 January 2021

Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct

1 reference

7 January 2021

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

1 reference

7 January 2021

Reversal of Indian childhood cirrhosis by D-penicillamine therapy

1 reference

7 January 2021

Reversibility of hepatic fibrosis in autoimmune hepatitis

1 reference

7 January 2021

Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis

1 reference

7 January 2021

Reversibility of cirrhosis in autoimmune hepatitis

1 reference

7 January 2021

The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis

1 reference

7 January 2021

Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment

1 reference

7 January 2021

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

1 reference

7 January 2021

Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.

1 reference

7 January 2021

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

7 January 2021

Reversibility of hepatitis C virus-related cirrhosis

1 reference

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

7 January 2021

Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations

1 reference

7 January 2021

Cirrhosis reversal: a duel between dogma and myth

1 reference

7 January 2021

Measurement of liver-iron concentration in needle-biopsy specimens

1 reference

7 January 2021

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

7 January 2021

Importance of specimen size in accurate needle liver biopsy evaluation of patients with chronic hepatitis C.

1 reference

7 January 2021

Contribution of obesity to hepatitis C-related fibrosis progression

1 reference

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

7 January 2021

Excess weight risk factor for alcoholic liver disease

1 reference

7 January 2021

Steatosis is a cofactor in liver injury in hemochromatosis

1 reference

7 January 2021

Screening for hemochromatosis in asymptomatic subjects with or without a family history

1 reference

7 January 2021

Comments on cirrhosis reversal

1 reference

7 January 2021

Hepatocellular carcinoma in primary haemochromatosis in the absence of cirrhosis

1 reference

7 January 2021

Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases.

1 reference

7 January 2021

Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report

1 reference

7 January 2021

Hepatocellular carcinoma arising in non-cirrhotic liver in genetic haemochromatosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21260

1 reference

25 February 2018

1 reference

25 February 2018